Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer

Journal of Internal Medicine

Volumn 265, Issue 5, 2009, Pages 616-617

  Thornton, S N ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR;

BLADDER CANCER; BLOOD VOLUME; COLON CANCER; DIABETES MELLITUS; ENZYME RELEASE; ENZYME SYNTHESIS; EXTRACELLULAR FLUID; FLUID INTAKE; HYPERTENSION; HYPOVOLEMIA; LETTER; NEOPLASM; OBESITY; PATHOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ANGIOTENSINS; BLOOD VOLUME; DIABETES MELLITUS; HUMANS; HYPERTENSION; NEOPLASMS; OBESITY;

EID: 64249092946     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.02037.x     Document Type: Letter

References (15)

1. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 2008 264 : 224 36.
2. Francischetti EA, Celoria BM, Francischetti A, Genelhu VA. Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan. Expert Rev Cardiovasc Ther 2008 6 : 289 303.
3. Gradman AH, Kad R. Renin inhibition in hypertension. J Am Coll Cardiol 2008 51 : 519 28.
4. Hedner T, Narkiewicz K, Kjeldsen SE. The evolution of ACE inhibition - a turning point in cardiovascular medicine. Blood Press Suppl 2007 2 : 5 6.
5. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008 26 : 831 43.
6. Perkins JM, Davis SN. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control. Curr Opin Endocrinol Diabetes Obes 2008 15 : 147 52.
7. Heffelfinger SC. The renin angiotensin system in the regulation of angiogenesis. Curr Pharm Des 2007 13 : 1215 29.
8. Molteni A, Heffelfinger S, Moulder JE, Uhal B, Castellani WJ. Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy. Anticancer Agents Med Chem 2006 6 : 451 60.
9. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 1998 78 : 583 686.
10. Valtin H. "Drink at least eight glasses of water a day." Really? Is there scientific evidence for "8 × 8"? Am J Physiol Regul Integr Comp Physiol 2002 283 : R993 1004.
11. Negoianu D, Goldfarb S. Just add water. J Am Soc Nephrol 2008 19 : 1041 3.
12. Eichelbaum EJ, Vesely BA, Alli AA, Sun Y, Gower WR Jr., Vesely DL. Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours. Endocrine 2006 30 : 325 32.
13. Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR Jr., Vesely DL. Four cardiac hormones cause cell death of melanoma cells and inhibit their DNA synthesis. Am J Med Sci 2007 334 : 342 9.
14. Ruskoaho H, Lang RE, Toth M, Ganten D, Unger T. Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J 1987 8 (Suppl. B 99 109.
15. Altieri A, La Vecchia C, Negri E. Fluid intake and risk of bladder and other cancers. Eur J Clin Nutr 2003 57 (Suppl. 2 S59 68.